Previous Page  27 / 186 Next Page
Information
Show Menu
Previous Page 27 / 186 Next Page
Page Background

CORPORATE GOVERNANCE

2

REMUNERATION AND BENEFITS IN KIND ALLOCATED BY THE COMPANY AND OTHER GROUP ENTITIES IN 2016

TO MEMBERS OF THE ADMINISTRATIVE AND MANAGEMENT BODIES IN OFFICE

2.2

REMUNERATION AND BENEFITS IN KIND ALLOCATED BY THE

COMPANY AND OTHER GROUP ENTITIES IN 2016 TO MEMBERS

OF THE ADMINISTRATIVE AND MANAGEMENT BODIES IN OFFICE

Recommendation of the AFEP-MEDEF Code not applied by Assystem

Explanation

Defined benefit supplementary pension plans should be subject to the condition

that the beneficiary must be an officer or employee of the Company when

he or she claims their pension pursuant to the applicable rules and regulations.

Not applicable.

Hedging instruments for performance shares.

Performance shares whose vesting conditions have been met are allocated

to the beneficiaries out of treasury stock.

2.2.1

REMUNERATION OF MEMBERS

OF THE BOARD OF DIRECTORS

The remuneration of directors takes the form of directors’ fees and is

based on (i) directors’ actual attendance at Board and Committee

meetings and (ii) their level of responsibility.

Following the new governance structure approved by shareholders

at the Annual General Meeting held on 22 May 2014, at its first

meeting on 22 May 2014 the Board of Directors indicated that the rules

previously governing the allocation of attendance fees for Supervisory

Board members would remain unchanged under the Company’s

new governance structure (

i.e.

with a Board of Directors instead of

a Supervisory Board) and specified that only independent directors

would be remunerated. However, at its meeting of 29 April 2015, after

closely studying Salvepar’s situation, the Board authorised Salvepar to

also receive directors’ fees.

At the Annual General Meeting of 24 May 2016, the Company’s

shareholders set the total amount of directors’ fees at €200,000 for

2016.

At its meeting of 7 November 2016, the Board approved the

Nominations and Remuneration Committee’s proposed allocation of

directors’ fees. These fees were paid on 16 November 2016.

A breakdown of the fees paid in 2015 and 2016 to members of the Board of Directors is provided in the following table:

Name

Title

Paid in 2015

for 2015

(in euros)

Paid in 2016

for 2016

(in euros)

Gilbert Lehmann

Director, Chairman of the Audit Committee and member of the Nominations

and Remuneration Committee

63,409

69,231

Miriam Maes

Director, Chair of the Nominations and Remuneration Committee

and member of the Audit Committee

49,318

53,846

Salvepar

Director, member of the Audit Committee and of the Nominations

and Remuneration Committee

42,273

46,154

Vincent Favier

Permanent representative of Salvepar

Virginie Calmels

Director

24,615

Total

155,000

193,846

At its meeting on 7 March 2017, in accordance with Articles 19 and

22 of the November 2016 version of the AFEP-MEDEF Code, the Board

of Directors decided that:

all of the Company’s directors – except Dominique Louis and Salvepar

who are already indirect shareholders of Assystem – will be required

to invest a portion of their directors’ fees in Assystem shares over the

next three years until the total amount invested corresponds to 10%

of their annual directors’ fees received;

Philippe Chevallier will be required to invest a portion of his annual

remuneration in Assystem shares over the next two years until the total

amount invested corresponds to 10% of his annual remuneration.

2.2.2

REMUNERATION OF THE COMPANY’S

EXECUTIVE OFFICERS

At 31 December 2016, the Company’s executive officers were:

Dominique Louis, Chairman & CEO since 22 May 2014;

Philippe Chevallier, CFO & Deputy CEO since 5 June 2015.

ASSYSTEM

REGISTRATION DOCUMENT

2016

27